745433
Last Update Posted: 2023-11-02
Recruiting has ended
All Genders accepted | 18 Years + |
906 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
This study is conducted in Europe. The aim of this observational study is to investigate the efficacy (e.g. glycemic control) and safety (e.g. hypoglycemic episodes) when adding repaglinide to a monotherapy of metformin in type 2 diabetic patients under normal clinical practice
Eligibility
Relevant conditions:
Diabetes
Diabetes Mellitus, Type 2
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov